TY  - GEN
AU  - Berger,Raanan
AU  - Rotem-Yehudar,Rinat
AU  - Slama,Gideon
AU  - Landes,Shimon
AU  - Kneller,Abraham
AU  - Leiba,Merav
AU  - Koren-Michowitz,Maya
AU  - Shimoni,Avichai
AU  - Nagler,Arnon
TI  - Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies
SN  - 1078-0432
PY  - 2008///0818
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antigens, CD
KW  - metabolism
KW  - Antineoplastic Agents
KW  - Apoptosis Regulatory Proteins
KW  - Area Under Curve
KW  - Dose-Response Relationship, Drug
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Female
KW  - Hematologic Neoplasms
KW  - drug therapy
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Programmed Cell Death 1 Receptor
N1  - Publication Type: Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1158/1078-0432.CCR-07-4079
ER  -